WHOLE BODY LED LIGHT THERAPY BEDS
GLOBAL LEADER: The ARRC LED is a global leader in the US based manufacturing of Full Body LED Light Therapy Beds. Our systems range from the mid dose, non-thermal 110 V EDGE POLY to our high dose 220V, 5000 watt ATP platform, and our new affordable 6000 watt MAX platform.
INNOVATOR: ARRC LED is and will continue to be an innovator and disrupter within the emerging full body light therapy bed industry. In 2020 alone we are introducing two new patent pending LED Light Therapy beds and initiating a number of clinical trials to evaluate how a whole body light therapy machine affects the body.
PRECISE DOSE & POWER: The ARRC LED ATP system is extraordinarily powerful within the optimum dosing ranges for LED Light Therapy. Rather than quoting ‘up to’ energy which is an inaccurate representation of a system, our mission is to instead optimize each individual wavelength for the canopy and the bench with total power as high as one can get without overdosing. Optimizing wavelengths translates to shorter treatment times and deeper penetration into tissues and joints.
TECHNOLOGICAL LEADER: ATP RF is a Patent Pending, Condition Specific, Resonant Frequency Full Body Light Therapy bed that will integrate multiple technologies into single treatments. We anticipate ATP RF to create a revolution within the energy medicine industry as it merges multiple treatment modalities to augment specific medical diagnostics.
BROAD MARKET: Our LED Light Therapy Beds can be found in the homes of world leaders, corporate executives and in the training rooms of professional sports teams. Doctors are prescribing PBM for their patients, recovery centers are offering it for athletes and alternative health seekers. Spas are using PBM to help their clients look better from head to toe. The appeal of PBMt is broad and the ARRC LED presents multiple solutions to meet diverse needs of each population.
CREATING THE FUTURE: Researchers continue to conclude that some of the mechanisms behind LED Light Therapy or PBMt are still uncertain. Our belief is that there are multiple wavelengths of energy that create slightly different healing signatures inside the body. Green for example might differ in how it affects blood cells and therefor be more active for diabetic, neuropathy, acne and shingles patients as well as wound helaing. Red and infrared both have their own healing signatures. Even within each color, we believe that healing signatures vary. 420nm blue may be most effective for acne, while 450nm blue is better for SAD and 470nm blue is best for MRSA. They are all blue and each slight variation has different benefits.
Beyond increased wavelengths and pulsing options for a full body led light therapy bed the ARRC LED is already integrating diagnositic augmentation with combination therapies and testing.
Recent photobiomodulation research (2019) into better understanding the mechanisms of Light Therapy may challenge the theory that LED light therapy is only beneficial if it is Red/NIR and presnts primary benefits only when absorbed and primarily activates CCO in the mitochondria. Both Green and Blue have proven themselves effective in clinical trails for pain relief, with blue being given FDA Approval for pain relief via Phillips.
PHOTOBIOMODULATION RESEARCH ADVISOR: The ARRC LED is honored to have Dr Michael Hamblin, MIT/Harvard, arguably the leading expert in photobiomodulation research as our advisor. Dr Hamblin has been extraordinarily helpful in determining dose as well as answering questions posed by our system owners about how Full Body Light Therapy might treat specific conditions.
Call 855.502.2772 for Direct Consultation to learn more about how a full body LED Light Therapy Bed from the ARRC LED may be applied to your practice, the costs of operation, expectations and comparisons between ATP and other systems:
The EDGE, ATP and ATP RF and upcoming Max system LED Light Therapy Beds are designed, engineered and built in the USA.
Our systems are built in an ISO 9001, Military and FDA compliant manufacturing facility according to GMP, FDA Quality Management Systems and ISO protocols.
The ARRC LED is FDA Registered. The FDA allows for low level light therapy devices to be sold ‘over the counter’ (FDA Exempt), with the only claim of ‘minor aches and pains’.
The ARRC LED makes no claims as to the effectiveness of its systems for any condition other than minor aches and pains. Always consult with your doctor when treating a medical condition. The ARRC LED does not offer any medical advice, always consult with your physician when treating a condition..
This says it all.
Read what researchers from Mass General, Harvard and Boston University conclude about LED Light Therapy.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790317 2.8. Downstream cellular response
There have been a large number of both animal model and clinical studies that demonstrated highly beneficial LLLT effects on a variety of diseases, injuries, and has been widely used in both chronic and acute conditions (see Figure 7). LLLT may enhance neovascularisation, promote angiogenesis and increase collagen synthesis to promote healing of acute (Hopkins et al. 2004) and chronic wounds (Yu et al. 1997). LLLT provided acceleration of cutaneous wound healing in rats with a biphasic dose response favoring lower doses (Corazza et al. 2007). LLLT can also stimulate healing of deeper structures such as nerves (Gigo-Benato et al.2004), tendons (Fillipin et al. 2005), cartilage (Morrone et al. 2000), bones (Weberet al. 2006) and even internal organs (Shao et al. 2005). LLLT can reduce pain (Bjordal et al. 2006a), inflammation (Bjordal et al. 2006b) and swelling (Carati et al. 2003) caused by injuries, degenerative diseases or autoimmune diseases. Oron reported beneficial effect of LLLT on repair processes after injury or ischemia in skeletal and heart muscles in multiple animal models in vivo (Ad and Oron 2001; Oron et al. 2001a; Oron et al. 2001b; Yaakobi et al. 2001). LLLT has been used to mitigate damage after strokes (in both animals (Lapchak et al. 2008) and humans (Lampl et al. 2007), after traumatic brain injury (Oron et al. 2007) and after spinal cord injury (Wu et al. 2009).
Beneficial tissue effects of LLLT can include almost all the tissues and organs of the body.